Entera Bio Ltd. 8-K

What Happened
Entera Bio Ltd. announced its financial results for the year ended December 31, 2025 and provided business updates via a press release issued March 27, 2026. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8‑K (filed March 27, 2026) and incorporated it by reference into the 8‑K.

Key Details

• Press release issued and furnished on March 27, 2026 announcing results for the fiscal year ended December 31, 2025 (Exhibit 99.1).
• Item disclosures in the 8‑K include Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• Exhibit list under Item 9.01 includes Exhibit 99.1 (press release) and Exhibit 104 (Cover Page Interactive Data File, Inline XBRL).

Why It Matters
The filing notifies investors that Entera Bio has publicly released its 2025 financial results and operational updates; those details can affect investor assessment of company performance and outlook. Because the release was furnished and accompanied by Regulation FD disclosure, the information was broadly distributed to the market and made available in machine‑readable form (Inline XBRL) for analysts and investors to review. For specific figures and forward-looking commentary, investors should read the Exhibit 99.1 press release and the company’s SEC filings.